Search research articles
Contact Us
Filters
Showing results (1-10 of 18) with videos related to
Page
of 2
Sort By:
Journal of Atrial Fibrillation
|
December 19, 2017
The Nonvitamin K Antagonist Oral Anticoagulants and Atrial Fibrillation: Challenges and Considerations
Anna Plitt, Sameer Bansilal
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions
|
February 7, 2018
Cardiac enzyme elevation after coronary revascularization
Anna Plitt, George Dangas
Cardiology and Therapy
|
March 12, 2018
A Review of the Role of Non-Vitamin K Oral Anticoagulants in the Acute and Long-Term Treatment of Venous Thromboembolism
Andrew Bromley, Anna Plitt
Future Cardiology
|
April 26, 2014
Edoxaban or standard therapy with warfarin for stroke prevention in patients with atrial fibrillation?
Anna Plitt, Robert P Giugliano
Journal of Cardiovascular Pharmacology and Therapeutics
|
March 11, 2014
Edoxaban: Review of pharmacology and key phase I to III clinical trials
Anna Plitt, Robert P Giugliano
Hospital Practice (1995)
|
September 26, 2014
Target-specific oral anticoagulants: practice issues for the clinician
Anna Plitt, Robert P Giugliano
The American Journal of Cardiology
|
May 8, 2019
Thromboembolism in the Absence of Atrial Fibrillation
Jeffrey Smietana, Anna Plitt, Jonathan L Halperin
JAMA Cardiology
|
January 26, 2017
Atrial Fibrillation, Type 2 Diabetes, and Non-Vitamin K Antagonist Oral Anticoagulants: A Review
Anna Plitt, Darren K McGuire, Robert P Giugliano
Hematology/Oncology Clinics of North America
|
September 18, 2016
Non-Vitamin K Antagonist Oral Anticoagulants in Atrial Fibrillation
Anna Plitt, Christian T Ruff, Robert P Giugliano
JAMA Cardiology
|
June 29, 2017
Major Bleeding in Patients With Diabetes and Atrial Fibrillation Treated With New Oral Anticoagulants-Reply
Anna Plitt, Darren K McGuire, Robert P Giugliano
Page
of 2
Search research articles
Search
Showing results (1-10 of 18) with videos related to
Sort By:
Page
of 2
Journal of Atrial Fibrillation
|
December 19, 2017
The Nonvitamin K Antagonist Oral Anticoagulants and Atrial Fibrillation: Challenges and Considerations
Anna Plitt, Sameer Bansilal
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions
|
February 7, 2018
Cardiac enzyme elevation after coronary revascularization
Anna Plitt, George Dangas
Cardiology and Therapy
|
March 12, 2018
A Review of the Role of Non-Vitamin K Oral Anticoagulants in the Acute and Long-Term Treatment of Venous Thromboembolism
Andrew Bromley, Anna Plitt
Future Cardiology
|
April 26, 2014
Edoxaban or standard therapy with warfarin for stroke prevention in patients with atrial fibrillation?
Anna Plitt, Robert P Giugliano
Journal of Cardiovascular Pharmacology and Therapeutics
|
March 11, 2014
Edoxaban: Review of pharmacology and key phase I to III clinical trials
Anna Plitt, Robert P Giugliano
Hospital Practice (1995)
|
September 26, 2014
Target-specific oral anticoagulants: practice issues for the clinician
Anna Plitt, Robert P Giugliano
The American Journal of Cardiology
|
May 8, 2019
Thromboembolism in the Absence of Atrial Fibrillation
Jeffrey Smietana, Anna Plitt, Jonathan L Halperin
JAMA Cardiology
|
January 26, 2017
Atrial Fibrillation, Type 2 Diabetes, and Non-Vitamin K Antagonist Oral Anticoagulants: A Review
Anna Plitt, Darren K McGuire, Robert P Giugliano
Hematology/Oncology Clinics of North America
|
September 18, 2016
Non-Vitamin K Antagonist Oral Anticoagulants in Atrial Fibrillation
Anna Plitt, Christian T Ruff, Robert P Giugliano
JAMA Cardiology
|
June 29, 2017
Major Bleeding in Patients With Diabetes and Atrial Fibrillation Treated With New Oral Anticoagulants-Reply
Anna Plitt, Darren K McGuire, Robert P Giugliano
Page
of 2